Monthly Archives:
September, 2016

  • FILTER

  1. Cernostics Receives Initial $1.3M of $5M Follow-On Investment

    Cernostics, an oncology diagnostics company whose unique technology enables “precision medicine,” has received a lead investment of $1.3 million toward its $5 million funding round by Novitas Capital and UPMC Enterprises, the commercialization arm of integrated healthcare system UPMC. Cernostics is a client of the Ben Franklin Technology Partners of Northeastern Pennsylvania (BFTP/NEP) and resides Continue Reading…